These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 17350670

  • 1. Immunohistochemical detection of antiapoptotic protein X-linked inhibitor of apoptosis in mammary carcinoma.
    Jaffer S, Orta L, Sunkara S, Sabo E, Burstein DE.
    Hum Pathol; 2007 Jun; 38(6):864-70. PubMed ID: 17350670
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical detection of X-linked inhibitor of apoptosis in head and neck squamous cell carcinoma.
    Nagi C, Xiao GQ, Li G, Genden E, Burstein DE.
    Ann Diagn Pathol; 2007 Dec; 11(6):402-6. PubMed ID: 18022123
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ.
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [Abstract] [Full Text] [Related]

  • 4. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
    Kwaepila N, Burns G, Leong AS.
    Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
    [Abstract] [Full Text] [Related]

  • 5. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S, Wang J, Bourne P, Yang Q, Tang P.
    Ann Clin Lab Sci; 2007 Apr; 37(2):127-34. PubMed ID: 17522367
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S, Kapucuoglu N, Baspinar S, Inan G, Candir O.
    Pathol Res Pract; 2006 Apr; 202(8):569-76. PubMed ID: 16828238
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
    Hoch BL, Wu M, Lewis M, Gan L, Burstein DE.
    J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
    [Abstract] [Full Text] [Related]

  • 11. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
    Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P.
    Hum Pathol; 2008 Mar; 39(3):386-92. PubMed ID: 18187183
    [Abstract] [Full Text] [Related]

  • 12. Prognostic value of the X-linked inhibitor of apoptosis protein for invasive ductal breast cancer with triple-negative phenotype.
    Wang J, Liu Y, Ji R, Gu Q, Zhao X, Liu Y, Sun B.
    Hum Pathol; 2010 Aug; 41(8):1186-95. PubMed ID: 20381828
    [Abstract] [Full Text] [Related]

  • 13. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 14. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P, Akram M, Benezra R, Brogi E.
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
    Pilichowska M, Kimura N, Fujiwara H, Nagura H.
    Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS, Apple SK.
    Breast J; 2009 Oct; 15(2):146-54. PubMed ID: 19292800
    [Abstract] [Full Text] [Related]

  • 18. Nuclear p53 protein accumulates preferentially in medullary and high-grade ductal but rarely in lobular breast carcinomas.
    Domagala W, Harezga B, Szadowska A, Markiewski M, Weber K, Osborn M.
    Am J Pathol; 1993 Mar; 142(3):669-74. PubMed ID: 8384406
    [Abstract] [Full Text] [Related]

  • 19. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression.
    Chiappetta G, Botti G, Monaco M, Pasquinelli R, Pentimalli F, Di Bonito M, D'Aiuto G, Fedele M, Iuliano R, Palmieri EA, Pierantoni GM, Giancotti V, Fusco A.
    Clin Cancer Res; 2004 Nov 15; 10(22):7637-44. PubMed ID: 15569996
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast.
    Gonzalez LO, Junquera S, del Casar JM, González L, Marín L, González-Reyes S, Andicoechea A, González-Fernández R, González JM, Pérez-Fernández R, Vizoso FJ.
    Hum Pathol; 2010 Jul 15; 41(7):980-9. PubMed ID: 20236691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.